Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: October 13, 2021
Reporting Period: Third quarter ended September 30, 2021
Context: The Company issued a press release announcing preliminary unaudited revenue for the third quarter of 2021 and provided a business update. This information is furnished pursuant to Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notice that preliminary unaudited revenue estimates for the third quarter ended September 30, 2021, were announced in a press release (Exhibit 99.1), which is incorporated by reference but not detailed within the text of this 8-K.
Material Changes
The filing does not contain specific comparative data or material changes versus the prior comparable period. It notes that the preliminary quarterly revenue estimate is subject to completion of audit and review procedures, which may result in adjustments to actual results.
Guidance, Outlook, and Risks
- Guidance: The Company has reiterated its 2021 total revenue guidance.
- Outlook: Actual results for the quarter ended September 30, 2021, and total revenues for the year ended December 31, 2021, could differ materially from the estimates provided.
- Risks and Contingencies: The filing cautions investors not to place undue reliance on forward-looking statements due to risks, uncertainties, and factors beyond the Company's control. Investors are directed to the "Risk Factors" section of the Annual Report on Form 10-K filed on March 11, 2021, for a discussion of important factors.
- Unusual Items: None explicitly detailed in the text; the primary focus is the preliminary nature of the revenue data.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 13, 2021) for the specific preliminary revenue figures and business update details.
- Verify the Company's reiterated 2021 total revenue guidance against the preliminary Q3 results.
- Consult the "Risk Factors" in the March 11, 2021, Form 10-K to understand potential variances between estimates and actual results.
- Monitor future filings for final audited results, as the current figures are preliminary and subject to adjustment.